par Dinh, Phuong ;de Azambuja, Evandro ;Cardoso, Fatima ;Piccart-Gebhart, Martine
Référence Nature clinical practice. Oncology, 5, 11, page (645-654)
Publication Publié, 2008-11
Référence Nature clinical practice. Oncology, 5, 11, page (645-654)
Publication Publié, 2008-11
Article révisé par les pairs
Titre: |
|
Auteur: | Dinh, Phuong; de Azambuja, Evandro; Cardoso, Fatima; Piccart-Gebhart, Martine |
Informations sur la publication: | Nature clinical practice. Oncology, 5, 11, page (645-654) |
Statut de publication: | Publié, 2008-11 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Belgium | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- economics | |
Breast Neoplasms -- genetics | |
Breast Neoplasms -- mortality | |
Chemotherapy, Adjuvant | |
Clinical Trials as Topic | |
Cost-Benefit Analysis | |
Female | |
Humans | |
Neoplasm Recurrence, Local -- economics | |
Neoplasm Recurrence, Local -- prevention & control | |
Phenotype | |
Receptor, erbB-2 -- genetics | |
Risk Assessment | |
Survival Analysis | |
Treatment Outcome | |
Tumor Markers, Biological -- genetics | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1743-4262 |
info:doi/10.1038/ncponc1219 | |
info:pii/ncponc1219 | |
info:scp/55549120522 | |
info:pmid/18779850 |